Donna H. Ryan, MD

Donna H. Ryan, MD, is professor emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, and past president of The Obesity Society.

Articles

The Evolving Perception and Utilization of Antiobesity Drugs: Expert Discussion

June 06, 2025

Donna Ryan, MD, highlights how the media has helped to reframe obesity as a chronic disease and how antiobesity drugs are transforming metabolic disease treatment.

Future of Obesity Care: 3 Wishes from Thought Leader Donna Ryan, MD

June 04, 2025

When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.

Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD

January 06, 2025

Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.

Emerging Obesity Research to Watch For in 2025

January 03, 2025

Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.

Expert Perspectives 2024: The Dynamic Future of Obesity Medicine, with Donna Ryan, MD

January 02, 2025

The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic disease.